Size self-limiting compositions and test devices for measuring analytes in biological fluids

Patent metadata

Field	Value
Publication number	US-9982289-B2
Application number	US-201113105375-A
Country	US
Kind code	B2
Filing date	May 11, 2011
Priority date	Dec 13, 2004
Publication date	May 29, 2018
Grant date	May 29, 2018

Abstract

A test strip or electrochemical sensor for measuring the amount of an analyte in a biological fluid, e.g. the glucose content of whole blood, includes a size self-limiting reagent formulation employing an enzyme system for reaction with the analyte, the reactive system mixed into a water-soluble swellable polymer matrix containing small water-insoluble particles having a nominal size of about 0.05 to 20 μm, preferably about 1 to 10 μm. The weight ratio of the water-insoluble particles to the water-soluble swellable polymer matrix is about 1/2 to 2/1. The reagent formulation is deposited onto a non-porous substrate to form a thin layer about 6-16 μm thick, providing a rapid and stable response to application of a sample, while being insensitive to the amount of the sample.

First claim

The invention claimed is:

1. A reactive formulation for measuring the amount of an analyte in a biological fluid comprising:
(a) a water-soluble swellable polymer matrix including water-insoluble particles having a nominal size of about 0.05 to 20 μm; and
(b) an enzyme system for reacting with said analyte,
wherein the weight ratio of said water-insoluble particles to said water-soluble swellable polymer matrix is about 1/2 to 2.1/1, wherein the reactive formulation has a thickness of about 6 to 16 μm.

2. The reactive formulation of claim 1 wherein said enzyme system is formulated to react with a member of the group consisting of glucose, lactate, cholesterol, triglycerides, free fatty acids, bilirubin, ascorbate, hydrogen peroxide and uric acid.

3. The reactive formulation of claim 1 wherein said analyte is glucose and the enzyme system includes a member of the group consisting of hexokinase, glucose-6-phosphate dehydrogenase, glucose dehydrogenase, glucose dehydrogenase-PQQ, and glucose oxidase.

4. The reactive formulation of claim 1 wherein said particles are at least one member of the group consisting of titanium dioxide, calcium carbonate, silica, barium sulfate, powdered metals, and latex.

5. The reactive formulation of claim 1 wherein said water-soluble swellable polymer matrix includes at least one member of the group consisting of polyacrylic acid, polyvinyl alcohol, polystyrene sodium sulfonic acid, polyacrylic latex, polyethylene glycol, styrene acrylates, and their co-polymers.

6. The reactive formulation of claim 1 further comprising at least one surfactant, detergent, or thickener.

7. The reactive formulation of claim 1 , wherein said coating has a thickness of 7 to 10 μm.

8. The reactive formulation of claim 1 wherein said water-soluble swellable polymer has a molecular weight below about 100,000.

9. The reactive formulation of claim 1 wherein said water-insoluble particles have a nominal size of about 1 to 10 μm.

10. A test strip for measuring the glucose content of whole blood samples comprising:
(a) a substantially non-porous substrate;
(b) a reagent layer disposed on said substrate, said reagent layer comprising;
(1) a water-soluble swellable polymer matrix including water-insoluble particles having a nominal size of about 0.05 to 20 μm;
(2) an enzyme system for oxidizing said glucose, and;
(3) an indicator;

(c) a protective covering for said reagent layer of (b).
(d) an adhesive layer between said reagent layer and said protective covering, said adhesive layer having a capillary channel for receiving said blood sample,
wherein the weight ratio of said water-insoluble particles to said water-soluble swellable polymer matrix is about 1/2 to 2.1/1, wherein the reagent layer has a thickness of about 6 to 16 μm.

11. The test strip of claim 10 wherein said enzyme system includes a member of the group consisting of hexokinase, glucose-6-phosphate dehydrogenase, glucose dehydrogenase, glucose dehydrogenase-PQQ, and glucose oxidase.

12. The test strip of claim 10 wherein said enzyme system comprises glucose dehydrogenase, a co-factor for said glucose dehydrogenase, a tetrazolium salt indicator, and a mediator.

13. The test strip of claim 10 wherein said water-soluble swellable polymer matrix is at least one member of the group consisting of polyacrylic acid, polyvinyl alcohol, polystyrene sodium sulfonic acid, polyacrylic latex, polyethylene glycol, styrene acrylates, and co-polymers thereof.

14. The test strip of claim 10 wherein said water-insoluble particles are at least one member of the group consisting of titanium dioxide, calcium carbonate, silica, barium sulfate, powdered metals, and latex.

15. The test strip of claim 10 wherein said polymer is dissolved in a solution buffered to maintain a desired pH.

16. The test strip of claim 10 wherein said reagent layer of (b) further comprises at least one surfactant, detergent, or thickener.

17. The test strip of claim 16 wherein said reagent layer has a thickness of 6 to 16 μm.

18. The test strip of claim 17 wherein said reagent layer has a thickness of 7 to 10 μm.

19. The test strip of claim 10 wherein said swellable polymer has a molecular weight below about 100,000.

20. The test strip of claim 10 wherein said particles have a nominal size of about 1 to 10 μm.

21. The reactive formulation of claim 1 , further comprising an indicator.

22. The reactive formulation of claim 1 , wherein said reactive formulation is applied as a single film.

23. The reactive formulation of claim 1 , wherein said analyte is glucose and said enzyme system comprises glucose dehydrogenase, a co-factor for said glucose dehydrogenase, a tetrazolium salt indicator, and a mediator.

24. The reactive formulation of claim 1 , wherein said water-soluble swellable polymer is dissolved in a solution buffered to maintain a desired pH.

25. The test strip of claim 10 , wherein said reactive formulation is applied as a single film.

Assignees

• Marfurt Karen L
• Ascensia Diabetes Care Holdings Ag

Inventors

• Marfurt Karen L

Classifications

• G01N33/523

  the element being adapted for a specific analyte · CPC title

• G01N33/50

  Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing (measuring or testing processes involving enzymes or microorganisms, compositions or test papers therefor; processes for forming such compositions, condition responsive control in microbiological or enzymological processes C12Q) · CPC title

• C12Q1/61

  involving triglycerides · CPC title

• G01N15/00

  Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials · CPC title

• C12Q1/54 Primary

  involving glucose or galactose · CPC title